Dr. Firas R. Muwalla, MD

Dr. Muwalla practices at Platte Valley Hospital in Brighton, Colorado, part of Intermountain Health.

Dr. Muwalla's NPI, 1013979566, was assigned on April 3, 2006. Dr. Muwalla graduated from University of Jordan Faculty of Medicine in 1992. Dr. Muwalla's Florida license number on file is ME94732.

Dr. Muwalla's primary practice is Platte Valley Hospital, at 1600 Prairie Center Pkwy, Brighton, CO 80601 in Adams County. The practice phone is (303) 498-1600.

Dr. Muwalla's primary practice is Platte Valley Hospital in Brighton, Colorado, part of Intermountain Health. Dr. Muwalla is also affiliated with Saint Joseph Hospital. The medical group on file is Mercyhealth Physicians. Dmand AI also links Dr. Muwalla to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muwalla practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Muwalla's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Muwalla is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Muwalla's licenses on file in 3 states: Florida, Colorado and Arkansas.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Muwalla treats.

CMS data shows 373 Medicare services from Dr. Muwalla across 5 procedure codes in 2024, all of them office visits, for 181 Medicare patients. Medicare paid $30,524 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 181 Medicare patients who saw Dr. Muwalla in 2024. The largest group is 65 to 74, with 94 patients. 70% of them have high blood pressure, and 66% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muwalla's median patient age at 72, with 64% women.

In 2024, Dr. Muwalla wrote 542 Medicare Part D claims for 81 patients. 56% of them were for generic drugs. CMS names the drug for 440 of them, across 22 drugs with 11 or more claims each, at $1,914,779 in total drug cost. In 2023, CMS named 328 claims across 16 drugs.

Dr. Muwalla accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Muwalla in 2020. The most frequent topics are Multiple Myeloma, Transplantation, Autologous and Antineoplastic Combined Chemotherapy Protocols. Dr. Muwalla has published most often in Br J Haematol. Dr. Muwalla's most frequent co-authors are Elias Anaissie, MD, Bart Barlogie, MD and Guido Tricot, MD.

Dmand AI links Dr. Muwalla to 2 clinical trials. Conditions studied include Leukemia, Myeloid, Chronic-Phase, Lymphoma, Follicular and Leukemia, Myelogenous, Chronic, BCR-ABL Positive.

CMS Open Payments shows 556 general payments to Dr. Muwalla from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,764.

Dmand AI lists 2 awards for Dr. Muwalla, most recently Regional Top Doctor in 2014.

Dr. Muwalla graduated from University of Jordan Faculty of Medicine in 1992.

Dr. Muwalla is in network with 11 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.